Product Information
CLONAZEPAM 0.125 MG DIS TAB is a generic product labeled by Par Health USA, LLC, priced at $0.5417 per EA under NDC 49884030602. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
.125 mg/1
Manufacturer
Par Health USA, LLCNDC
49884030602
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077171On Market Since
8/5/2005
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.125 MG DIS TAB has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 30.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5417 per EA |
|---|---|
| All-time high | $0.8730 (Aug 12, 2015) |
| All-time low | $0.4221 (Jul 17, 2024) |
| 52-week high | $0.6134 |
| 52-week low | $0.4835 |
| Median price | $0.6649 |
| Average price | $0.6548 |
| Largest weekly change | +47.8% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the clonazepam market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.125 MG DIS TAB?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.125 MG DIS TAB, manufactured by Par Health USA, LLC, is $0.5417 per EA (NDC 49884030602), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.125 MG DIS TAB changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.125 MG DIS TAB has declined 30.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.125 MG DIS TAB?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 0.125 MG DIS TAB has ranged from a low of $0.4221 (Jul 17, 2024) to a high of $0.8730 (Aug 12, 2015), with a median of $0.6649 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.125 MG DIS TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLONAZEPAM 0.125 MG DIS TAB, so no direct lower-cost alternative is listed.
Who manufactures CLONAZEPAM 0.125 MG DIS TAB?
CLONAZEPAM 0.125 MG DIS TAB (NDC 49884030602) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification